Is this a big breakthrough?
1 Like
Could very well be.
The other major hurdle is specificity. CRISPR/Cas9 has the tendency to edit off-target at really low rates, but at high enough rates to worry scientists and doctors about potentially lethal and ethically challenging side effects.
3 Likes